Evaluation of a pen device for self-adminstration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction

Reproductive BioMedicine Online

Volumn 9, Issue 4, 2004, Pages 373-380

  Kettel, L M ^a   Scholl, G ^b   Bonaventura, L ^c   Pang, S ^d   Sacks, P ^e   Chantilis, S ^f   Mahony, M ^g  

^a San Diego Research Center   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c Midwest Reproductive Medicine   (United States)

^d Reproductive Science Center   (United States)

^e Columbia Fertility Associates   (United States)

^f PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^g Organon Pharmaceuticals USA Inc   (United States)

Author keywords

FSH; Infertility; Ovulation induction; Pen injector

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN BETA SUBUNIT; PLACEBO; RECOMBINANT FOLLITROPIN;

ADULT; ANOVULATION; ARTICLE; ASTHMA; CELL SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPREHENSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SELF ADMINISTRATION; EDEMA; ERYTHEMA; FEMALE; HUMAN; MENSTRUAL CYCLE; MULTICENTER STUDY; OPEN STUDY; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PAIN; PREGNANCY RATE; PRURITUS; QUESTIONNAIRE; SAFETY; SELF INJECTION; SKIN BRUISING;

EID: 5044234719     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61272-2     Document Type: Article

References (21)

1. Amer SAK, Li TC, Ledger WL 2004 Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Human Reproduction 19, 1719-1724.
2. Balasch J, Tur R, Peinado JA 1996 The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. Journal Assisted Reproduction and Genetics 13, 551-556.
3. Balen AH 1993 Hypersecretion of LH: a significant cause of infertility and miscarriage. British Journal of Obstetrics and Gynaecology 100, 1082-1089.
4. Barbieri RL 2003 Metformin for the treatment of polycystic ovary syndrome. Obstetrics and Gynecology 101, 785-793.
5. Bohannon NJ 1999 Insulin delivery using pen devices - simple to use tools may help young and old alike. Postgraduate Medicine 106, 57-68.
6. Coelingh Bennink HJ, Fauser BC, Out HJ 1998 Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Fertility and Sterility 69, 19-25.
7. Craenmehr E, Bontje PM, Hoomans E et al. 2001 Follitropin-β administered by pen device has superior local tolerance compared with follitropin-α administered by conventional syringe. Reproductive BioMedicine Online 3, 185-189.
8. De Leo V, la Marca A, Ditto A et al. 1999 Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertility and Sterility 72, 282-285.
9. Garcia JE, Kettel LM, Klein NA et al. 2004 An aqueous formulation of recombinant human FSH is more efficient than a freeze-dried cake formulation in clomiphene-resistant women with chronic anovulation. Today's Therapeutic Trends 22, 147-165.
10. Gysler M, March CM, Mishell DR Jr, Baily EJ 1982 A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertility and Sterility 37, 161-167.
11. Hayden CJ, Rutherford AJ, Balen AH 1999 Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon). Fertility and Sterility 71, 106-108.
12. Imani B, Eijkemans MJC, te Velde ER et al. 1998 Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Journal Clinical Endocrinology and Metabolism 83, 2361-2365.
13. Kadiri A, Chraibi A, Marouan F et al. 1998 Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM subjects with secondary failure to oral hypoglycaemic agents. Diabetes Research and Clinical Practice 41, 15-23.
14. Kousta E, White DM, Franks S 1997 Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update 3, 359-365.
15. Lord JM, Flight IHK, Norman RJ 2003 Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 327, 1-6.
16. Out HJ, Coelingh Bennink HJT 1998 Clomiphene citrate in the twenty-first century: an anachronism? Assisted Reproduction Reviews 8, 94-101.
17. Pang S, Kaplan B, Karande V, et al. 2003 Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation. Reproductive BioMedicine Online 7, 319-326.
18. Platteau P, Laurent E, Albano C et al. 2003 An open, randomized, single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alfa administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Human Reproduction 18, 1-5.
19. Sucic M, Galic E, Cabrijan T et al. 2002 Patient acceptance and reliability of new Humulin®/Humalog® 3.0 ml prefilled insulin pen in ten Croatian diabetes centres. Medical Science Monitor 8, 121-126.
20. Voortman G, Post van de J, Schoemaker RC, Gerven van MA 1999 Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon®) by Pen-injector and syringe. Human Reproduction 14, 1698-1702.
21. World Health Organization 1999 WHO Laboratory Manual for the Examination of Human Semen and Semen - Cervical Mucus Interaction, 4th edn. Cambridge University Press, Cambridge.